UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tibia shaft fractures: costly burden of nonunions

BMC musculoskeletal disorders, 2013-01, Vol.14 (1), p.42-42, Article 42

2013

Volltextzugriff (PDF)

Burden of paediatric influenza in Western Europe: a systematic review

BMC public health, 2012-11, Vol.12 (1), p.968-968, Article 968

2012

Volltextzugriff (PDF)

Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.474-481

2016

Volltextzugriff (PDF)

Older people presenting to the emergency department after a fall: a population with substantial recurrent healthcare use

Emergency medicine journal : EMJ, 2012-09, Vol.29 (9), p.742-747

2012

Volltextzugriff (PDF)

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO

Annals of allergy, asthma, & immunology, 2017-12, Vol.119 (6), p.524-532.e2

2017

Volltextzugriff (PDF)

Validity and Responsiveness of Urticaria Activity and Impact Measure (U-AIM), a New Patient-Reported Tool to Assess Disease Activity and Impact in Patients with Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU)

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB49-AB49

2018

Volltextzugriff (PDF)

Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study

Journal of the American Academy of Dermatology, 2018-04, Vol.78 (4), p.793-795

2018

Volltextzugriff (PDF)

Morbidities Associated with Chronic Oral Glucocorticoid Exposure in Children with Asthma: A Real-World Analysis of Medical and Pharmacy Claims

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB219-AB219

2018

Volltextzugriff (PDF)

Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio

Journal of managed care & specialty pharmacy, 2017-11, Vol.23 (11), p.1117-1124

2017

Volltextzugriff (PDF)

Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies

Annals of allergy, asthma, & immunology, 2016-10, Vol.117 (4), p.370-377.e1

2016

Volltextzugriff (PDF)

Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria

Annals of allergy, asthma, & immunology, 2017-04, Vol.118 (4), p.524-524

2017

Volltextzugriff (PDF)

Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis

ClinicoEconomics and outcomes research, 2016-01, Vol.8, p.641-648

2016

Volltextzugriff (PDF)

My Hives Diary: An Ios App to Track Urticaria Symptoms

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB131-AB131

2015

Volltextzugriff (PDF)

Poor Asthma Control Is Associated with Overall Daily Activity Impairment: 3-Year Data from the EXCELS Study of Omalizumab

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB14-AB14

2016

Volltextzugriff (PDF)

Study Design, Baseline and Open-Label Results from XTEND-CIU: A Phase IV, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Omalizumab through 48 Weeks in Patients with Chronic Idiopathic Urticaria

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB271-AB271

2017

Volltextzugriff (PDF)

Allergen Sensitization Is Associated with Increased Rates of Exacerbations, Oral Corticosteroid (OCS) Use, and Asthma-Related Healthcare Services in Children with Severe or Poorly Controlled Asthma

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB205-AB205

2017

Volltextzugriff (PDF)

Higher Immunoglobulin E (IgE) Levels Are Associated with Greater Emergency Care and Other Healthcare Utilization Among Asthma Patients in a Real-World Data Setting

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB9-AB9

2016

Volltextzugriff (PDF)

Decreased Asthma Exacerbations and Hospitalizations in PROSPERO (Prospective Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab)

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB8-AB8

2017

Volltextzugriff (PDF)

Clinically Significant Improvements in Asthma Patient-Reported Outcomes: Results from the Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab (PROSPERO) Study

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB9-AB9

2017

Volltextzugriff (PDF)

Corticosteroid-Related Adverse Events in Chronic Idiopathic Urticaria

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB125-AB125

2015

Volltextzugriff (PDF)

Response Patterns in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Patients Treated with Omalizumab for 24 Weeks in Two Randomized, Double-Blind, Placebo-Controlled Clinical Trials (ASTERIA I and GLACIAL)

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB127-AB127

2015

Volltextzugriff (PDF)

Scope and Severity Index: A Metric for Quantifying Nursing Home Survey Deficiency Number, Scope, and Severity Adjusted for the State-Related Measurement Bias

Journal of the American Medical Directors Association, 2012-02, Vol.13 (2), p.188.e7-188.e12

2012

Volltextzugriff (PDF)

Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria

American journal of clinical dermatology, 2015-08, Vol.16 (4), p.313-321

2015

Volltextzugriff (PDF)

Prevalence and Correlates of Osteoporosis in US Men

Journal of clinical densitometry, 2010, Vol.13 (1), p.112-113

2010

Volltextzugriff (PDF)

Corticosteroid-related toxicity in patients with chronic idiopathic urticaria‐chronic spontaneous urticaria

Allergy and asthma proceedings, 2016-11, Vol.37 (6), p.458-465

2016

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tibia shaft fractures: costly burden of nonunions

Burden of paediatric influenza in Western Europe: a systematic review

Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria

Older people presenting to the emergency department after a fall: a population with substantial recurrent healthcare use

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO

Validity and Responsiveness of Urticaria Activity and Impact Measure (U-AIM), a New Patient-Reported Tool to Assess Disease Activity and Impact in Patients with Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU)

Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study

Morbidities Associated with Chronic Oral Glucocorticoid Exposure in Children with Asthma: A Real-World Analysis of Medical and Pharmacy Claims

Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio

Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies

Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria

Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis

My Hives Diary: An Ios App to Track Urticaria Symptoms

Poor Asthma Control Is Associated with Overall Daily Activity Impairment: 3-Year Data from the EXCELS Study of Omalizumab

Study Design, Baseline and Open-Label Results from XTEND-CIU: A Phase IV, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Omalizumab through 48 Weeks in Patients with Chronic Idiopathic Urticaria

Allergen Sensitization Is Associated with Increased Rates of Exacerbations, Oral Corticosteroid (OCS) Use, and Asthma-Related Healthcare Services in Children with Severe or Poorly Controlled Asthma

Higher Immunoglobulin E (IgE) Levels Are Associated with Greater Emergency Care and Other Healthcare Utilization Among Asthma Patients in a Real-World Data Setting

Decreased Asthma Exacerbations and Hospitalizations in PROSPERO (Prospective Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab)

Clinically Significant Improvements in Asthma Patient-Reported Outcomes: Results from the Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab (PROSPERO) Study

Corticosteroid-Related Adverse Events in Chronic Idiopathic Urticaria

Response Patterns in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Patients Treated with Omalizumab for 24 Weeks in Two Randomized, Double-Blind, Placebo-Controlled Clinical Trials (ASTERIA I and GLACIAL)

Scope and Severity Index: A Metric for Quantifying Nursing Home Survey Deficiency Number, Scope, and Severity Adjusted for the State-Related Measurement Bias

Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria

Prevalence and Correlates of Osteoporosis in US Men

Corticosteroid-related toxicity in patients with chronic idiopathic urticaria‐chronic spontaneous urticaria

Suchergebnisse filtern